Please Wait
Applying Filters...
menu
    • menu
    Nanoalvand-PSE
    News
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Menu

    NanoAlvand

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-71771.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-90057.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/197-forbes

    PRESS RELEASE
    09 Dec 2024
    Share Share
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/191-ifoxa-release

    PRESS RELEASE
    30 Nov 2024
    Share Share
    Introducing Vicrista® – A New Era in Pediatric Oncology
    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/192-vicrista-release

    PRESS RELEASE
    03 Nov 2024
    Share Share
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters

    22 Oct 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/190-top-exporters

    PRESS RELEASE
    22 Oct 2024
    Share Share
    Endoxyna®; A crucial medication with a novel solution formulation
    Endoxyna®; A crucial medication with a novel solution formulation

    29 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    29 Jun 2024
    Share Share
    Nibulin®; From the coast of Japan sea to hands of clinicians
    Nibulin®; From the coast of Japan sea to hands of clinicians

    08 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    08 Jun 2024
    Share Share